About Atypical hemolytic uremic syndrome with complement gene abnormality
Atypical hemolytic uremic syndrome with complement gene abnormality is a rare disease catalogued by Orphanet (ORPHA:544472). It is associated with the THBD, C3, CD46 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Atypical hemolytic uremic syndrome with complement gene abnormality trials.
Search ClinicalTrials.gov for "Atypical hemolytic uremic syndrome with complement gene abnormality" or filter by Orphanet code ORPHA:544472 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Atypical hemolytic uremic syndrome with complement gene abnormality trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Atypical hemolytic uremic syndrome with complement gene abnormality. Updated daily.